PRICE BRANDON (Senior VP Business Development) reported 2 transactions at NASCENT BIOTECH INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/6/2020ACC: 0001477932-20-000067
DirectorOfficer10% Owner· Senior VP Business Development
+756.70K
Net shares
Net buyer
$75.7K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
756.70K acquired
Non-Derivative Transactions2
Common Stock (conversion of debt to equity)
Direct
Shares
+700K
Price / share
$0.10
Trade value
$70K
% of position
41.9%
—
1.67M→2.37M
Common Stock
Direct
Shares
+56.70K
Price / share
$0.10
Trade value
$5.67K
% of position
2.4%
—
2.37M→2.43M
Total
Net shares
+756.70K
Net value
$75.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock (conversion of debt to equity) Direct | — | J · J | +700K | $0.10 | $70K | 41.9% | 1.67M | 2.37M |
| Common Stock Direct | — | J · J | +56.70K | $0.10 | $5.67K | 2.4% | 2.37M | 2.43M |
| Total | +756.70K | $75.67K | ||||||
Derivative Transactions0
No derivative transactions reported